DOUGLAS CHARLES MACLELLAN
CIK 1200827 · Chief Executive Officer · last filed 2022-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.1K
Companies
3
Total Filings
32
Lifetime Open-Market Net
-$45.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-28 | RADIENT PHARMACEUTICALS Corp (ADL) Delisted | Mixed | — | -$16.5K | EDGAR |
| 2007-06-11 | RADIENT PHARMACEUTICALS Corp (ADL) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–32 of 32
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.